PRESS RELEASE published on 01/27/2026 at 17:40, 7 months 17 days ago VALBIOTIS SA: 2025 Un déploiement commercial en marche, matérialisé par une montée en puissance des revenus au 4ème trimestre VALBIOTIS SA : Forte croissance des revenus au 4ème trimestre 2025 et perspectives commerciales 2026. Expansion internationale avec partenariats en Asie et Moyen-Orient Croissance International Partenariats Valbiotis Revenus
REGULATED PRESS RELEASE published on 01/27/2026 at 17:40, 7 months 17 days ago Mersen: Change to the Board of Directors Mersen appoints Florence Lambert to Board of Directors, replacing Emmanuelle Picard. Lambert brings expertise in renewable energies and R&D Board Of Directors Mersen R&D Renewable Energies Florence Lambert
REGULATED PRESS RELEASE published on 01/27/2026 at 17:40, 7 months 17 days ago Mersen : Evolution au sein du Conseil d'administration Mersen annonce l'évolution au sein de son Conseil d’administration avec la démission de Madame Picard et la cooptation de Madame Lambert, experte en énergies renouvelables Énergies Renouvelables Mersen Conseil D’administration Évolution Démission
REGULATED PRESS RELEASE published on 01/27/2026 at 17:04, 7 months 17 days ago Nombre total de droits de vote et d'actions composant le capital social Communiqué de presse relatif aux droits de vote et actions de GROUPE SFPI. Les détails sont disponibles sur le site Internet de l'entreprise Autorité Des Marchés Financiers Groupe SFPI Droits De Vote Actions Informations Réglementées
PRESS RELEASE published on 01/27/2026 at 16:50, 7 months 17 days ago Linedata Services: Bilan semestriel du contrat de liquidité contracté avec la Société de Bourse Gilbert Dupont Linedata Services publie son bilan semestriel du contrat de liquidité avec la Société de Bourse Gilbert Dupont Euronext Paris Société De Bourse Gilbert Dupont Contrat De Liquidité Bilan Semestriel Linedata Services
PRESS RELEASE published on 01/27/2026 at 16:43, 7 months 17 days ago MHH to Present Scientific Findings on Cold Plasma Therapy for Pulmonary Application at Press Conference in February 2026 MHH to present groundbreaking cold plasma therapy for pulmonary application at press conference in February 2026, addressing urgent clinical need worldwide Scientific Findings Press Conference Viromed Medical AG Cold Plasma Therapy Pulmonary Application
PRESS RELEASE published on 01/27/2026 at 16:16, 7 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Dauch Corporation The Vanguard Group, Inc. discloses a 7.66% stake in Dauch Corporation through Form 8.3 filing on 27-Jan-2026 Form 8.3 Financial Filing Vanguard Group Stake Disclosure Dauch Corporation
PRESS RELEASE published on 01/27/2026 at 16:03, 7 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses 5.08% stake in JTC plc as of 26 Jan 2026. Purchased 2,750 1p ordinary securities at 12.91 GBP per unit The Vanguard Group Financial Disclosure Stake Disclosure Securities Purchase JTC Plc
PRESS RELEASE published on 01/27/2026 at 16:02, 7 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Glencore plc The Vanguard Group, Inc. discloses a 4.89% stake in Glencore plc. Additional disclosures regarding Rio Tinto plc and Rio Tinto Limited made Disclosure The Vanguard Group Stake Rio Tinto Glencore Plc
PRESS RELEASE published on 01/27/2026 at 16:01, 7 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses 6.02% stake in Avadel Pharmaceuticals plc as of 26 Jan 2026 via Form 8.3 with US$0.01 ordinary shares purchases The Vanguard Group, Inc. Form 8.3 Share Purchases Stake Disclosure Avadel Pharmaceuticals Plc
Published on 09/12/2026 at 02:35, 1 day 22 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 2 days 2 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 2 days 4 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 2 days 8 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/13/2026 at 16:45, 8 hours 44 minutes ago Journées européennes du patrimoine : un succès populaire pour l'ouverture exceptionnelle du Siège de la Vaudoise
Published on 09/12/2026 at 17:50, 1 day 7 hours ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 17 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 2 days 3 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 2 days 3 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 07:00, 2 days 18 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 18 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 3 days 5 hours ago Availability of the 2026 Interim Financial Report
